Audio is streamed directly from the publisher (endocrine.org) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
We look into promising findings from clinical trials regarding Burosumab, a human monoclonal antibody designed for the treatment of X-linked hypophosphatemia. With us are Erik Imel, MD from the Indiana University School of Medicine and Suzanne Marie Jan De Beur, MD from Johns Hopkins University School of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.
Topics
endocrinephosphatehypophosphatemia